FX.co ★ Mangoceuticals To Defend Against Eli Lilly's Lawsuit Over Alleged Copying Of Weight-Loss Drugs

Mangoceuticals Inc. (MGRX) has reported that Eli Lilly has filed a lawsuit against them, accusing the company of unlawfully replicating its weight-loss drugs, Zepbound and Mounjaro. Mangoceuticals strongly refutes all accusations related to the sale of compounded tirzepatide, asserting that it possesses solid grounds to challenge Eli Lilly's claims and is determined to defend itself actively in this legal case.